TAZOBAC Side Effects

6888060-X | Accidental Exposure, Anaphylactic Reaction
on Jul 27, 2010 Female patient from PORTUGAL , 26 years of age, was treated with Tazobac (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, anaphylactic reaction. Tazobac dosage: .

6868030-8 | Accidental Overdose, Agranulocytosis, Cardiac Failure, Extrapyramidal Disorder, Neutropenia, Respiratory Failure, Sedation, Systemic Inflammatory Response Syndrome
Patient was taking Tazobac (View Usage). Patient had the following side effects: accidental overdose, agranulocytosis, cardiac failure, extrapyramidal disorder, neutropenia, respiratory failure, sedation, systemic inflammatory response syndrome on Jul 14, 2010 from SWITZERLAND Additional patient health information: Female patient , weighting 17.64 lb, was diagnosed with pneumonia bacterial, off label use and. Tazobac dosage: . During the same period patient was treated with CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), CHLORAL HYDRATE (Dosage Not Provided) (View Chloral Hydrate Review and Chloral Hydrate Label ), MORPHINE (Dates And Dosage Not Provided) (View Morphine Review and Morphine Label ), VALIUM (View Valium Review and Valium Label ), CATAPRESAN (View Catapresan Review and Catapresan Label ). Patient was hospitalized.

6836576-4 | Blood Amylase Increased, Cholecystitis, Hepatitis, Hepatocellular Injury, Lipase Increased
Adverse event was reported on Jul 01, 2010 by a Male patient taking Tazobac (View Usage) (Dosage: ) was diagnosed with escherichia bacteraemia, pseudomonas infection and. Location: SWITZERLAND , 23 years of age, After Tazobac was administered, patient had the following side effects: blood amylase increased, cholecystitis, hepatitis (What is hepatitis?), hepatocellular injury, lipase increased. During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), NEXIUM (View Nexium Review and Nexium Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ).

6451369-8 | Condition Aggravated, Creatinine Renal Clearance Decreased, Rash Macular, Rash Pruritic
on Nov 18, 2009 Male patient from SWITZERLAND , 90 years of age, weighting 215.0 lb, was diagnosed with endocarditis (What is endocarditis?), oral infection and was treated with Tazobac (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, creatinine renal clearance decreased, rash macular, rash pruritic. Tazobac dosage: . During the same period patient was treated with CIPROXINE (View Ciproxine Review and Ciproxine Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), EFFORTIL (View Effortil Review and Effortil Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), COMBIVENT (View Combivent Review and Combivent Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), REMERON (View Remeron Review and Remeron Label ). Patient was hospitalized.


6408967-7 | Blood Creatine Phosphokinase Increased, Chills
on Oct 14, 2009 Male patient from SWITZERLAND , 56 years of age, was diagnosed with bacterial infection (What is bacterial infection?) and was treated with Tazobac (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, chills. Tazobac dosage: . Patient was hospitalized.

6375843-8 | Condition Aggravated, International Normalised Ratio Increased
Patient was taking Tazobac (View Usage). After Tazobac was administered, patient had the following side effects: condition aggravated, international normalised ratio increased on Sep 22, 2009 from SWITZERLAND Additional patient health information: Female patient , 63 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Tazobac dosage: . During the same period patient was treated with CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISONE TAB (Alternating 20 And 15 Mg Per Day) (View Prednisone Tab Review and Prednisone Tab Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), NEXIUM (View Nexium Review and Nexium Label ), SPORANOX (View Sporanox Review and Sporanox Label ), BELOC ZOK (View Beloc Zok Review and Beloc Zok Label ), VALCYTE (View Valcyte Review and Valcyte Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ). Patient was hospitalized.

6212157-0 | Gastroenteritis Clostridial
Adverse event was reported on May 27, 2009 by a Male patient taking Tazobac (View Usage) (Dosage: ) was diagnosed with tracheobronchitis, prophylaxis, organ transplant (What is organ transplant?), osteoporosis (What is osteoporosis?), pulmonary embolism (What is pulmonary embolism?), polyneuropathy, cardiovascular event prophylaxis and. Location: GERMANY , 60 years of age, weighting 235.9 lb, Patient experienced the following unwanted or unexpected effects: gastroenteritis clostridial. During the same period patient was treated with COTRIMHEXAL FORTE (View Cotrimhexal Forte Review and Cotrimhexal Forte Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), DECORTIN H (View Decortin-h Review and Decortin-h Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), FALITHROM (As Required After Inr Control) (View Falithrom Review and Falithrom Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LOCOL (View Locol Review and Locol Label ). Patient was hospitalized.

6150673-0 | Pseudomembranous Colitis, Weight Decreased
on Apr 09, 2009 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with abscess (What is abscess?), type 2 diabetes mellitus, hyperuricaemia, pseudomembranous colitis, hypertension, atrial fibrillation (What is atrial fibrillation?), hypercholesterolaemia and was treated with Tazobac (View Usage). Patient had the following side effects: pseudomembranous colitis, weight decreased. Tazobac dosage: . During the same period patient was treated with INSULIN ACTRAPHANE (32 Iu Per Day) (View Insulin Actraphane Review and Insulin Actraphane Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), DELIX (View Delix Review and Delix Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), FALITHROM (View Falithrom Review and Falithrom Label ), LOCOL (View Locol Review and Locol Label ). Patient was hospitalized.

5424151-8 | Dyspnoea, Fatigue, Hypersensitivity, Oxygen Saturation Decreased, Respiratory Arrest
on Aug 20, 2007 Female patient from SWITZERLAND , 23 years of age, was diagnosed with cystic fibrosis and was treated with Tazobac (View Usage). After Tazobac was administered, patient had the following side effects: dyspnoea, fatigue, hypersensitivity, oxygen saturation decreased, respiratory arrest. Tazobac dosage: .

5394166-7 | Grand Mal Convulsion, Hypokalaemia
Patient was taking Tazobac (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion, hypokalaemia on Jun 22, 2007 from SWITZERLAND Additional patient health information: Female patient , 83 years of age, weighting 147.7 lb, was diagnosed with pneumonia bacterial, cardiac failure congestive, sleep disorder (What is sleep disorder?), atrial fibrillation (What is atrial fibrillation?), atrial flutter, essential hypertension, epilepsy (What is epilepsy?), constipation (What is constipation?) and. Tazobac dosage: . During the same period patient was treated with TORSEMIDE (View Torsemide Review and Torsemide Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), SINTROM (View Sintrom Review and Sintrom Label ), BELOC (View Beloc Review and Beloc Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DEPAKENE (View Depakene Review and Depakene Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ). Patient was hospitalized.

5392322-5 | Hypersensitivity, Respiratory Arrest
Adverse event was reported on Jul 17, 2007 by a Female patient taking Tazobac (View Usage) (Dosage: ) was diagnosed with cystic fibrosis and. Location: SWITZERLAND , 23 years of age, Patient had the following side effects: hypersensitivity, respiratory arrest.

5360634-7 | Breast Cancer Metastatic, Cholestasis, Concomitant Disease Progression, Sinus Tachycardia
on Jun 08, 2007 Female patient from SWITZERLAND , 71 years of age, was diagnosed with pneumonia bacterial and was treated with Tazobac (View Usage). After Tazobac was administered, patient had the following side effects: breast cancer metastatic, cholestasis, concomitant disease progression, sinus tachycardia. Tazobac dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), DURAGESIC 100 (Transdermal) (View Duragesic-100 Review and Duragesic-100 Label ), HALDOL (View Haldol Review and Haldol Label ), NEXIUM (View Nexium Review and Nexium Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5274088-2 | Condition Aggravated, Epilepsy, Hyponatraemia, Leukoencephalopathy, Stupor
on Mar 16, 2007 Female patient from SWITZERLAND , 48 years of age, was diagnosed with pneumonia (What is pneumonia?), epilepsy (What is epilepsy?) and was treated with Tazobac (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, epilepsy (What is epilepsy?), hyponatraemia, leukoencephalopathy, stupor. Tazobac dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), MORPHINE (1 Dose Every 1 Prn) (View Morphine Review and Morphine Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), TIENAM (500 Mg Every 1 Tot) (View Tienam Review and Tienam Label ). Patient was hospitalized.

5268817-1 | Cerebral Haemorrhage, Thrombocytopenia
Patient was taking Tazobac (View Usage). Patient had the following side effects: cerebral haemorrhage, thrombocytopenia on Mar 15, 2007 from GERMANY Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with bronchitis bacterial, prophylaxis against gastrointestinal ulcer, hypertension and. Tazobac dosage: . During the same period patient was treated with DECORTIN (50 Mg) (View Decortin Review and Decortin Label ), ACETYLSALICYLIC ACID SRT (100 Mg) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PANTOPRAZOLE SODIUM (40 Mg) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METOPROLOL SUCCINATE (47.5 Mg) (View Metoprolol Succinate Review and Metoprolol Succinate Label ).

5266105-0 | Eosinophilia, Exfoliative Rash, Pyrexia, Skin Hyperpigmentation
Adverse event was reported on Mar 13, 2007 by a Female patient taking Tazobac (View Usage) (Dosage: ) was diagnosed with pyrexia, c-reactive protein increased, meningitis cryptococcal, enterocolitis bacterial, tremor and. Location: SWITZERLAND , 53 years of age, After Tazobac was administered, patient had the following side effects: eosinophilia, exfoliative rash, pyrexia, skin hyperpigmentation. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), FLAGYL (View Flagyl Review and Flagyl Label ), MYSOLINE (View Mysoline Review and Mysoline Label ).

5265101-7 | Cardiovascular Disorder, Respiratory Failure, Sepsis
on Mar 14, 2007 Male patient from GERMANY , 53 years of age, was diagnosed with neutropenic infection, pyrexia and was treated with Tazobac (View Usage). Patient experienced the following unwanted or unexpected effects: cardiovascular disorder, respiratory failure, sepsis (What is sepsis?). Tazobac dosage: . During the same period patient was treated with DIFLUCAN (800 Mg) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5253009-2 | Cardiovascular Disorder, Respiratory Failure, Sepsis
on Feb 26, 2007 Male patient from GERMANY , 53 years of age, was diagnosed with neutropenic infection, pyrexia and was treated with Tazobac (View Usage). Patient had the following side effects: cardiovascular disorder, respiratory failure, sepsis (What is sepsis?). Tazobac dosage: . During the same period patient was treated with DIFLUCAN (800 Mg) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5251216-6 | Cardiovascular Disorder, Respiratory Failure, Sepsis
Patient was taking Tazobac (View Usage). After Tazobac was administered, patient had the following side effects: cardiovascular disorder, respiratory failure, sepsis (What is sepsis?) on Feb 26, 2007 from GERMANY Additional patient health information: Male patient , 53 years of age, was diagnosed with neutropenic infection, pyrexia and. Tazobac dosage: . During the same period patient was treated with DIFLUCAN (800 Mg) (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5247356-8 | Eosinophilia, Exfoliative Rash, Pyrexia, Skin Hyperpigmentation
Adverse event was reported on Feb 23, 2007 by a Female patient taking Tazobac (View Usage) (Dosage: ) was diagnosed with pyrexia, c-reactive protein increased, meningitis cryptococcal, enterocolitis bacterial, tremor and. Location: SWITZERLAND , 53 years of age, Patient experienced the following unwanted or unexpected effects: eosinophilia, exfoliative rash, pyrexia, skin hyperpigmentation. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), FLAGYL (View Flagyl Review and Flagyl Label ), MYSOLINE (View Mysoline Review and Mysoline Label ).

5246462-1 | Cholangitis, Cholelithiasis, Hepatitis Toxic, Jaundice Cholestatic
on Feb 21, 2007 Male patient from SWITZERLAND , 72 years of age, was diagnosed with schizophrenia, paranoid type, peripheral vascular disorder, hyperlipidaemia, tachycardia paroxysmal, left ventricular failure, osteomyelitis and was treated with Tazobac (View Usage). Patient had the following side effects: cholangitis, cholelithiasis, hepatitis toxic, jaundice cholestatic. Tazobac dosage: . During the same period patient was treated with SEROQUEL (View Seroquel Review and Seroquel Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), AMIODARONE HYDROCHLORIDE (View Amiodarone Hydrochloride Review and Amiodarone Hydrochloride Label ), TRIATEC (View Triatec Review and Triatec Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), LIQUEMINE (View Liquemine Review and Liquemine Label ), CIPROFLOXACIN HYDROCHLORIDE (750 Mg + 500 Mg Per Day) (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ). Patient was hospitalized.

4777321-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Chills, Diarrhoea, Eosinophilia, Gamma-glutamyltransferase Increased, Gastrointestinal Disorder
on Sep 02, 2005 Male patient from SWITZERLAND , 52 years of age, was diagnosed with osteomyelitis and was treated with Tazobac (View Usage). After Tazobac was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, diarrhoea, eosinophilia, gamma-glutamyltransferase increased, gastrointestinal disorder. Tazobac dosage: 4.5 G 3x Per 1 Day, Intravenous. During the same period patient was treated with DAFALGAN (PARACETAMOL, 0 ) (1000 Mg 4x Per) (View Dafalgan (paracetamol, 0 ) Review and Dafalgan (paracetamol, 0 ) Label ), PANTOZOL (PANTOPRAZOLE) (40 Mg 1x Per 1 Day, Intravenous) (View Pantozol (pantoprazole) Review and Pantozol (pantoprazole) Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.